Podcast in English
Text size
Bulgarian National Radio © 2024 All Rights Reserved

Bulgarian medicine shows good results in treatment of Covid-19 patients

Photo: EPA/BGNES

The anti-parasitic drug Ivermectin may be effective in the treatment of patients with coronavirus. As early as May, a trial of the drug began in Bulgaria, as the team is entirely Bulgarian and 30 patients have already been recruited in 9 hospitals.

The study in Bulgaria began after information from Australian scientists in April and clinical studies on patients in Spain, Brazil and the United States. The director of the Bulgarian Drug Agency, Bogdan Kirilov, said that the drug has been used for decades against various infections and therefore the drug itself has a known safety profile.



Последвайте ни и в Google News Showcase, за да научите най-важното от деня!
Listen to the daily news from Bulgaria presented in "Bulgaria Today" podcast, available in Spotify.

More from category

Mural unveiled in Bulgaria's Plovdiv dedicated to 20 years of Bulgaria's NATO membership

In the presence of diplomats, Bulgarian Foreign Minister Ivan Kondov unveiled in Plovdiv the latest mural from the ministry's competition "Bulgaria - More Beautiful in NATO". The event is dedicated to the 20th anniversary of the country's membership in..

published on 12/21/24 9:45 AM

Weather forecast: Yellow weather alert for rain and snow in 21 regions of the country

On Saturday, a cold front will sweep across the country. During the night there will be rain in Western and Central Bulgaria, and snow in the mountains and on higher ground. A snow cover will form. Minimum temperatures 1-6° C., for Sofia around 1°..

published on 12/20/24 6:35 PM

Traffic on the Danube Bridge near Ruse has been temporarily restored

Traffic on the Danube Bridge near Bulgaria's Ruse on the border with Romania has been temporarily restored in both directions as of today . Due to the expected increased traffic through the border crossing during the upcoming Christmas and New Year..

published on 12/20/24 6:18 PM